Myelodysplastic/myeloproliferative neoplasms

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are rare clonal myeloid disorders.
• These neoplasms exhibit overlapping features of myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).
• The 2008 World Health Organization classification identifies distinct subtypes: chronic myelomonocytic leukemia (CMML), atypical chronic myeloid leukemia (aCML), and juvenile myelomonocytic leukemia (JMML), with a provisional category for MDS/MPN, unclassifiable (MDS/MPN, U).

Purpose of the Study:

• To provide an overview of MDS/MPN entities.
• To focus on adult MDS/MPN, particularly CMML.
• To highlight recent advances in understanding the molecular pathogenesis of MDS/MPN.

Main Methods:

• Review of current literature and classification systems.
• Focus on array technologies and next-generation sequencing insights.
• Discussion of clinical, laboratory, and morphologic findings.

Main Results:

• Significant progress in understanding the molecular pathogenesis of CMML and JMML.
• New insights derived from array technologies and deep sequencing.
• Distinct features aid in classifying most cases into recognized subtypes.

Conclusions:

• MDS/MPN are complex hematologic malignancies requiring precise classification.
• Advances in molecular biology are crucial for understanding MDS/MPN pathogenesis.
• This review focuses on adult MDS/MPN, with CMML as a primary area of interest.